Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
01/2007
01/24/2007EP1072598B9 Pyrazolinone derivatives
01/24/2007CN1902186A Thiazole and pyrazole derivatives as FLT-3 kinase inhibitors
01/24/2007CN1901971A Cyclopropane compounds and pharmaceutical use thereof
01/24/2007CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical
01/23/2007US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them
01/23/2007US7166619 Compounds for treatment of diseases associated with prenylation of proteins
01/23/2007US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
01/23/2007US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/23/2007US7166593 Glucocorticoid receptor modulators
01/23/2007CA2234246C Water dispersible blocked isocyanates
01/18/2007WO2007007042A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
01/18/2007US20070015918 Derivatives of 1,3-diones having a herbicidal activity
01/18/2007US20070015811 5(S)-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments
01/18/2007US20070015810 5(R)-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments
01/18/2007US20070015809 Substituted pyrazoles, indazoles, 1,2,3-triazoles, or benzotriazoles; anticarcinogenic agents, antiinflammatory agents, antiarthritic agents, transplant rejection; controlled release formulations; aralkylation and amidation of the indazole compound
01/18/2007US20070015762 NPY Y5 antagonist
01/18/2007US20070015756 For therapy of hyperproliferative diseases
01/18/2007US20070015664 2,4,6-Phenyl substituted cyclic ketoenols
01/18/2007US20070012935 Organic electroluminescent device
01/17/2007EP1743892A1 Substituted pyrazoline compounds, their preparation and use as medicaments
01/17/2007EP1743890A1 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
01/17/2007EP1743889A1 Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
01/17/2007EP1743888A1 Carbonyl substituted pyrazoline compounds, their preparation and use as CB1 receptor modulators
01/17/2007EP1743887A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators
01/17/2007EP1742942A1 Phenylthioacetic acid derivatives and use thereof
01/17/2007EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
01/17/2007EP1742923A1 Pyrazole phenyl derivatives as ppar activators
01/17/2007EP1742922A1 Crystalline pyrazole derivative
01/17/2007EP1742921A2 Pyrazole derivatives useful for the treatment of cancer
01/17/2007EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof
01/17/2007EP1742908A1 Non-nucleoside reverse transcriptase inhibitors
01/17/2007EP1742907A2 Certain chemical entities, compositions, and methods
01/17/2007EP1542679B1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv
01/17/2007CN1898213A Heteroaroyl-substituted phenylalanineamides with herbicidal action
01/17/2007CN1897813A Plant growth regulation
01/17/2007CN1896070A 2- and 2,5-substituted phenylketo-enols
01/17/2007CN1896066A Preparation of Insecticide
01/17/2007CN1896060A Tetrahydro-indolone and tetrahydro-indazolone derivatives and their use
01/17/2007CN1295221C Substituted heterocyclic compounds
01/11/2007WO2007003419A1 Heterocyclic compounds as agonists for the thyroid receptor
01/11/2007WO2007003056A1 Cathepsin cysteine protease inhibitors
01/11/2007WO2006129178A8 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
01/11/2007US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
01/11/2007US20070010563 Novel methods for the treatment of inflammatory diseases
01/11/2007US20070010561 Prenylation inhibitors and methods of their synthesis and use
01/11/2007US20070010555 Indazole having analgesic activity
01/11/2007US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide
01/11/2007US20070010531 Substituted pyrazole compounds
01/11/2007US20070010530 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma
01/11/2007US20070010491 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye
01/11/2007US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
01/11/2007DE102005025989A1 Carboxamide Carboxamides
01/11/2007CA2614070A1 Cathepsin cysteine protease inhibitors
01/11/2007CA2612591A1 Heterocyclic compounds as agonists for the thyroid receptor
01/10/2007EP1740579A1 Tricyclic pyrazole kinase inhibitors
01/10/2007EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives
01/10/2007EP1740538A2 Bicyclic heterocycles useful as serine protease inhibitors
01/10/2007CN1894240A 阿片受体拮抗剂 Opioid receptor antagonist
01/10/2007CN1894235A N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
01/10/2007CN1894219A Optically active carboxamids and use thereof to combat undersirable microorganisms
01/10/2007CN1894218A Pyrazolinols used as pesticides
01/10/2007CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
01/10/2007CN1894202A Benzoyl-substituted phenylalanine amides
01/10/2007CN1894190A Method for the production of tetrahydrogeranylacetone
01/10/2007CN1893825A Substituted arylpyrazoles as parasiticidal agents
01/10/2007CN1294121C Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage
01/10/2007CN1293809C Fungicide mixture
01/09/2007US7161006 Enzyme inhibitors for treatment of Alzhemer's Disease
01/09/2007US7160923 Polyamine analogues as therapeutic and diagnostic agents
01/09/2007US7160908 Platinum amine glycine complex derivatives; antiproliferative and antitumor agents; side effect reduction; reversibly active; on and off
01/09/2007US7160907 Pleuromutilin derivatives
01/09/2007US7160870 Thrombopoietin mimetics
01/04/2007WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/04/2007WO2007000334A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
01/04/2007WO2007000329A2 Epoxidation of alpha, beta-unsaturated ketones
01/04/2007WO2006073610A3 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
01/04/2007WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors
01/04/2007US20070004924 Synthesis of diaryl pyrazoles
01/04/2007US20070004921 Isopentyl carboxanilides for combating undesired micro-organisms
01/04/2007US20070004755 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma
01/04/2007US20070004754 Substituted pyrazoles
01/04/2007US20070004747 Substituted pyrazoles
01/04/2007US20070004738 Substituted pyrazoles
01/04/2007DE102005028293A1 Verfahren zum Herstellen von Carboxamiden A process for the manufacture of carboxamides
01/04/2007CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/03/2007EP1739134A1 Azo compound
01/03/2007EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
01/03/2007EP1737857A1 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
01/03/2007EP1737446A2 Fused heterocyclic compounds
01/03/2007EP1265850B1 Insecticidal anthranilamides
01/03/2007EP1223944B1 Thrombopoietin mimetics
01/03/2007EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
01/03/2007CN1890246A Pyrazolopyrimidines
01/03/2007CN1889949A PDK-1/Akt signaling inhibitors
01/03/2007CN1889947A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
01/03/2007CN1293254C Aqueous liquid formulations of pyrazoline brighteners
01/03/2007CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
01/03/2007CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides
01/03/2007CN1292746C Pharmaceutical composition administered orally comprising amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and antioxidate
01/02/2007US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions